Pharming Group N.V. (AMS:PHARM)
1.417
-0.007 (-0.49%)
Apr 28, 2026, 5:35 PM CET
Pharming Group Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,001 | 977 | 627 | 690 | 707 | 503 | Upgrade
|
| Market Cap Growth | 102.95% | 55.71% | -9.08% | -2.41% | 40.66% | -38.05% | Upgrade
|
| Enterprise Value | 947 | 947 | 587 | 658 | 657 | 487 | Upgrade
|
| Last Close Price | 1.42 | 1.43 | 0.93 | 1.03 | 1.08 | 0.78 | Upgrade
|
| PE Ratio | 412.14 | 402.37 | - | - | 55.27 | 35.75 | Upgrade
|
| Forward PE | 53.92 | - | - | 153.88 | 27.10 | 14.49 | Upgrade
|
| PS Ratio | 3.12 | 3.05 | 2.19 | 3.11 | 3.68 | 2.88 | Upgrade
|
| PB Ratio | 4.24 | 4.14 | 2.94 | 3.49 | 3.69 | 2.96 | Upgrade
|
| P/TBV Ratio | 8.30 | 8.10 | 4.06 | 5.17 | 5.82 | 5.23 | Upgrade
|
| P/FCF Ratio | 21.78 | 21.26 | - | - | 35.85 | 21.10 | Upgrade
|
| P/OCF Ratio | 21.48 | 20.97 | - | - | 33.66 | 15.11 | Upgrade
|
| EV/Sales Ratio | 2.96 | 2.96 | 2.05 | 2.97 | 3.41 | 2.78 | Upgrade
|
| EV/EBITDA Ratio | 25.44 | 28.07 | 188.69 | - | 40.97 | 18.22 | Upgrade
|
| EV/EBIT Ratio | 33.31 | 33.94 | - | - | 67.70 | 23.07 | Upgrade
|
| EV/FCF Ratio | 20.60 | 20.61 | - | - | 33.29 | 20.43 | Upgrade
|
| Debt / Equity Ratio | 0.42 | 0.42 | 0.51 | 0.78 | 0.82 | 0.84 | Upgrade
|
| Debt / EBITDA Ratio | 2.69 | 2.69 | 17.02 | - | 8.46 | 4.88 | Upgrade
|
| Debt / FCF Ratio | 2.15 | 2.15 | - | - | 7.91 | 5.97 | Upgrade
|
| Net Debt / Equity Ratio | -0.23 | -0.23 | -0.25 | -0.19 | -0.20 | -0.16 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.60 | -1.60 | -17.24 | 2.74 | -2.37 | -0.99 | Upgrade
|
| Net Debt / FCF Ratio | -1.17 | -1.17 | 21.50 | 2.24 | -1.93 | -1.11 | Upgrade
|
| Asset Turnover | 0.84 | 0.84 | 0.69 | 0.55 | 0.50 | 0.49 | Upgrade
|
| Inventory Turnover | 0.75 | 0.75 | 0.63 | 0.51 | 0.50 | 0.87 | Upgrade
|
| Quick Ratio | 1.97 | 1.97 | 2.96 | 3.28 | 3.90 | 4.69 | Upgrade
|
| Current Ratio | 2.59 | 2.59 | 3.77 | 4.06 | 4.65 | 5.33 | Upgrade
|
| Return on Equity (ROE) | 1.02% | 1.02% | -5.38% | -4.98% | 6.88% | 8.50% | Upgrade
|
| Return on Assets (ROA) | 4.55% | 4.55% | -0.52% | -3.06% | 1.57% | 3.68% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.92% | 3.41% | -2.10% | -12.76% | 5.79% | 10.98% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.50% | 8.50% | -1.10% | -5.70% | 2.80% | 6.80% | Upgrade
|
| Earnings Yield | 0.24% | 0.25% | -1.82% | -1.38% | 1.81% | 2.80% | Upgrade
|
| FCF Yield | 4.59% | 4.70% | -0.40% | -2.46% | 2.79% | 4.74% | Upgrade
|
| Buyback Yield / Dilution | -11.25% | -11.25% | -2.18% | 7.09% | -0.85% | -2.70% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.